Shields Health Solutions Demonstrates Industry Leading Clinical Outcomeshttps://shieldshealthsolutions.com/content/uploads/2025/05/PR-1024x1024.png10241024Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Across nearly 80 health system partners, Shields maintained high-quality care while experiencing annual growth in patient volume across diverse disease states STOUGHTON, Mass. (March 3, 2026) – Shields Health Solutions…
Shields Health Solutions Partners with Foundation Health, the Leading Pharmacy AI Platform, to Improve Patient and Provider Experience in Specialty Pharmacy Care Nationwidehttps://shieldshealthsolutions.com/content/uploads/2025/05/PR-1024x1024.png10241024Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
The partnership, and investment from Shields, aims to enhance workflows for high-touch medications with innovative pharmacy operations technology, improving patient experience and reducing administrative burden STOUGHTON, Mass. (Jan. 13, 2026)…
Shields Health Solutions and Lakeland Regional Health Collaborate to Enhance Patient Access to Specialty Pharmacy Carehttps://shieldshealthsolutions.com/content/uploads/2025/05/PR-1024x1024.png10241024Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
The partnership will support patients through personalized care, medications, and coordinationShields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country, has partnered with Lakeland Regional Health, one of…
Revenue and Patient Volume Associated with Accreditation Restricted Limited Distribution Drugs in Health System Specialty Pharmacieshttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Accreditation positions health system specialty pharmacies to expand access to high-value medications and supports integrated caremodels shown to reduce healthcare costs.
Ambulatory Clinical Pharmacist Impact on Coverage Determinations for Specialty Oncology Medicationshttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster evaluates the impact of an ambulatory clinical pharmacist (ACP) program on third party pharmacy coverage determinationoutcomes for specialty oncology medications prescribed from these clinics.
Evaluating Health System Time Demands and Challenges of Specialty Pharmacy Accreditationhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster evaluate the challenges, time commitments, and resource allocation associated withachieving and maintaining SP accreditation among health-system specialty pharmacies.
Analysis of Oral Oncolytic Waste for Patients Filling at a Health System Specialty Pharmacyhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster evaluates existing oral oncology medication waste events among patients filling at a health system specialty pharmacy (HSSP).
Treatment Utilization Patterns and Time To Therapy Discontinuation in Patients with ALK+ Metastatic Non-Small Cell Lung Cancerhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster explores treatment utilization patterns and time to discontinuation (TTD) in patients receiving ALK TKIs for ALK+ mNSCLC.
Clinical and Quality Outcomes of a Bleeding Disorder Program in a Health System Specialty Pharmacyhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster evaluates the clinical and quality outcomes of a bleeding disorder program in a health system specialty pharmacy.
The Impact of Re-Training Specialty Pharmacy Outreach Technicians and Optimizing Compliance and Productivityhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster assesses the impact of re-training for specialty pharmacy outreach technicians by evaluating improvements in compliance knowledge, technician productivity, and patient enrollment rates.